Trial Profile
A phase IIa trial of OPT-302 in patients with diabetic macular edema
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2017
Price :
$35
*
At a glance
- Drugs Sozinibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Opthea
- 06 Apr 2017 New trial record
- 02 Apr 2017 According to an Opthea media release, this trial is expected to initiate in the second half of 2017.